| Primary |
| Drug Use For Unknown Indication |
30.9% |
| Product Used For Unknown Indication |
26.9% |
| Weight Decreased |
15.3% |
| Decreased Appetite |
11.6% |
| Weight Increased |
2.4% |
| Cachexia |
1.6% |
| Endometrial Cancer |
1.6% |
| Appetite Disorder |
1.2% |
| Oral Intake Reduced |
1.2% |
| Anorexia |
0.8% |
| Anticoagulant Therapy |
0.8% |
| Neoplasm Malignant |
0.8% |
| Pain |
0.8% |
| Small Cell Lung Cancer Stage Unspecified |
0.8% |
| Underweight |
0.8% |
| Weight Control |
0.8% |
| Abnormal Loss Of Weight |
0.4% |
| Deep Vein Thrombosis |
0.4% |
| Failure To Thrive |
0.4% |
| Lung Neoplasm Malignant |
0.4% |
|
| Deep Vein Thrombosis |
31.5% |
| Death |
22.4% |
| Pulmonary Embolism |
7.7% |
| Oedema Peripheral |
7.0% |
| Vaginal Haemorrhage |
3.5% |
| Lung Disorder |
2.8% |
| Weight Decreased |
2.8% |
| Cerebrovascular Accident |
2.1% |
| Mobility Decreased |
2.1% |
| Oral Intake Reduced |
2.1% |
| Thrombosis |
2.1% |
| Visual Acuity Reduced |
2.1% |
| White Blood Cell Count Increased |
2.1% |
| Addison's Disease |
1.4% |
| Mental Status Changes |
1.4% |
| Neoplasm Malignant |
1.4% |
| Non-small Cell Lung Cancer |
1.4% |
| Renal Failure |
1.4% |
| Speech Disorder |
1.4% |
| Stevens-johnson Syndrome |
1.4% |
|
| Secondary |
| Product Used For Unknown Indication |
57.1% |
| Weight Decreased |
14.3% |
| Cachexia |
9.5% |
| Decreased Appetite |
9.5% |
| Endometrial Cancer |
9.5% |
|
| Death |
25.0% |
| Unresponsive To Stimuli |
25.0% |
| Deep Vein Thrombosis |
12.5% |
| Upper Gastrointestinal Haemorrhage |
12.5% |
| Visual Acuity Reduced |
12.5% |
| Visual Disturbance |
12.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
26.5% |
| Product Used For Unknown Indication |
22.5% |
| Vitamin Supplementation |
6.2% |
| Colorectal Cancer Metastatic |
6.0% |
| Prophylaxis |
5.9% |
| Non-small Cell Lung Cancer |
4.5% |
| Pain |
4.3% |
| Hypertension |
3.4% |
| Nausea |
2.3% |
| Anxiety |
2.2% |
| Multiple Myeloma |
2.2% |
| Premedication |
2.2% |
| Lung Neoplasm Malignant |
2.0% |
| Decreased Appetite |
1.9% |
| Rash |
1.5% |
| Medical Diet |
1.4% |
| Mineral Supplementation |
1.4% |
| Diabetes Mellitus |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Hypomagnesaemia |
1.2% |
|
| Weight Decreased |
19.3% |
| Death |
14.0% |
| Sepsis |
10.5% |
| Malignant Neoplasm Progression |
5.3% |
| Pain |
5.3% |
| Pneumonia |
5.3% |
| Small Intestinal Obstruction |
5.3% |
| White Blood Cell Count Decreased |
5.3% |
| Coronary Artery Occlusion |
3.5% |
| Fluid Retention |
3.5% |
| Hepatic Neoplasm Malignant |
3.5% |
| Urinary Tract Infection |
3.5% |
| Vomiting |
3.5% |
| Ammonia Increased |
1.8% |
| Atrial Fibrillation |
1.8% |
| Back Disorder |
1.8% |
| Cardiac Disorder |
1.8% |
| Cardiopulmonary Failure |
1.8% |
| Cerebrovascular Accident |
1.8% |
| Chest Pain |
1.8% |
|
